Dec 19, 2019 - Talking with CML, Cabral made clear that Veeva's approach to markets is one of carefully nurturing clientele over many years. It has taken a dozen years to bring its life sciences software business to the point where the technology is being used to manage clinical data for a massive Phase III trial run by one of the top-20 pharmaceutical companies in the world.
Nov 25, 2019 - We sat down with the CEO of Top Pick Five9 (FIVN) and what we experienced was a fantastic window into a CEO and his vision. This was a truly exceptional conversation.
Nov 15, 2019 - Invitae (NYSE:NVTA) launched an app on Apple Watch, available now, to study genomics of heart disease in conjunction with the American Heart Association's Scientific Sessions.
Nov 09, 2019 - The University of Vermont Initiates Genomic DNA Testing in Partnership With Genomics Leader Invitae (NYSE:NVTA) as Cigna Joins Invitae's Covered Lives Roster